Clinical trial
Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary…
NCT00317512 · Biopure Corporation, Industry · Completed
Key facts
| NCT number | NCT00317512 |
|---|---|
| Title | Pilot Study of Hemoglobin Based Oxygen Therapeutics in Elective Coronary Revascularization |
| Official title | A Multi-Center,Randomized,Double-Blind,Placebo-Controlled,Dose Finding Pilot Study, to Evaluate Safety/Feasibility of HBOC-201 in Elective Percutaneous Coronary Revascularization of Subjects With Acute Coronary Syndromes |
| Lead sponsor | Biopure Corporation, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Angina Pectoris, Unstable Angina, Myocardial Infarction |
| Intervention type | Drug, Procedure |
| Interventions | Percutaneous Coronary Revascularization, Hemoglobin-Based Oxygen Carrier-201 (HBOC-201), Voluven |
| Enrollment | 45 |
| Start date | Dec 1, 2003 |
| Primary completion | Apr 1, 2005 |
| Completion | Jul 1, 2007 |
| First posted | Apr 25, 2006 |
| Last update posted | May 16, 2008 |
| Countries | Belgium, Germany, Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: